Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT00972634
Collaborator
(none)
1,051
1
14
75.1

Study Details

Study Description

Brief Summary

RATIONALE: A computer-based system for assessing symptoms may be effective for patients with metastatic or advanced cancer.

PURPOSE: This clinical trial is studying how well computerized questionnaires work in assessing symptoms, pain, depression, and physical function in patients with metastatic and/or advanced local/regional cancer.

Condition or Disease Intervention/Treatment Phase
  • Other: computer-assisted intervention
  • Other: questionnaire administration
  • Procedure: assessment of therapy complications
  • Procedure: quality-of-life assessment

Detailed Description

OBJECTIVES:
  • Determine the feasibility of applying a computer-based system for symptom assessment and classification in palliative cancer care in patients with metastatic and/or advanced cancer.

  • Examine hypothesized differences across groups related to acceptance of computers (i.e., age, culture, stage of disease, cognitive and physical function, etc.).

  • Examine the general user-friendliness of the tool.

  • Test and validate the performance of selected domains and items for classification and assessment of pain and cachexia.

  • Explore the validity of domains and items for depression.

OUTLINE: This is a multicenter study.

All patients undergo computer-based assessments of general symptoms by the Edmonton Symptom Assessment System (ESAS) and the European Organization for Research and Treatment of Cancer Core Quality of Life (EORTC QLQ C30) questionnaires and assessment of physical function, appetite/weight loss, and depression by the Brief Patient Health Questionnaire 9 (PRIME-MD PHQ9). Patients who score ≥ 1 (on a 0-10 numerical rating score) on the pain screening question with or without occurrence of breakthrough pain (BTP), undergo the Alberta BTP Assessment tool assessing precipitating factors for pain, time to pain relief after intake of medication, and satisfaction with medication. Patients complete questions regarding user-friendliness and feasibility of using the computer at the end of their session.

Study Design

Study Type:
Observational
Actual Enrollment :
1051 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
The European Palliative Care Research Collaborative - Computerised Symptom Assessment and Classification of Pain, Depression and Physical Function (Cachexia) (EPCRC - CSA)
Study Start Date :
Oct 1, 2008
Actual Primary Completion Date :
Nov 1, 2009
Actual Study Completion Date :
Dec 1, 2009

Outcome Measures

Primary Outcome Measures

  1. Feasibility of applying a computer based system for symptom assessment and classification in palliative cancer care [Sept 2008-December 2009]

  2. Differences across groups related to acceptance of computers (i.e., age, culture, stage of disease, cognitive and physical function, etc.) [Sept 2008-December 2009]

  3. General user-friendliness of the tool [Sept 2008-December 2009]

  4. Performance of selected domains and items for classification and assessment of pain and cachexia [Sept 2008-December 2009]

  5. Validity of domains and items for depression [Sept 2008-December 2009]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Diagnosis of incurable cancer, including patients receiving life-prolonging treatment

  • Metastatic and/or advanced locoregional disease

PATIENT CHARACTERISTICS:
  • Able to provide written informed consent

  • Fluent in the language used at the study site

PRIOR CONCURRENT THERAPY:
  • No prior inclusion in this study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Norwegian University of Science and Technology Trondheim Norway N-7006

Sponsors and Collaborators

  • Norwegian University of Science and Technology

Investigators

  • Principal Investigator: Stein Kaasa, MD, Norwegian University of Science and Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00972634
Other Study ID Numbers:
  • CDR0000648077
  • NUST-EPCRC-CSA
  • EU-20962
First Posted:
Sep 7, 2009
Last Update Posted:
Jan 18, 2017
Last Verified:
Jan 1, 2017
Keywords provided by Norwegian University of Science and Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2017